increased circulating leptin level_Tg(Fabp4-Phb*Y114F)#Smis/0

http://metadb.riken.jp/0005669NSTgFabp4PhbY114FSmis0TgFabp4PhbY114FSmis

increased circulating leptin level_Tg(Fabp4-Phb*Y114F)#Smis/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion, Suresh Mishra
  http://metadb.riken.jp/db/mgi_rdf/MGI:5763308

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Fabp4-Phb*Y114F)#Smis/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Fabp4-Phb*Y114F)#Smis

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• Not Specified

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased circulating leptin level
  http://purl.obolibrary.org/obo/MP_0005669

文献

http://purl.org/net/cito/citesAsAuthority

• S R. Ande, et.al., Expression of a mutant prohibitin from the aP2 gene promoter leads to obesity-linked tumor development in insulin resistance-dependent manner., Oncogene, 2016, 35
  http://rdf.ncbi.nlm.nih.gov/pubmed/26751773